NIH PAR · NIDDK · U2C

PAR-26-115: Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Open for applicationsNext due date: May 25, 2027Expires May 27, 2028

Responding to the needs of the scientific community to bolster a vibrant and sustainable research workforce, the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has incorporated additional flexibilities for institutional training programs serving the mission interests of non-malignant kidney, urologic, and hematologic diseases, encompassing both adult and pediatric conditions. The purpose of this notice of funding opportunity is to invite applications for Institutional Network Awards (U2C-TL1) to recruit, train, and retain the next generation of researchers and provide them with the coordinated…

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-26-115
Type
PAR
Activity code
U2C
Primary institute
NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
Clinical trials
Not Allowed
Posted
Dec 10, 2025
Opens
Apr 25, 2026
Expires
May 27, 2028

PAR-26-115 due dates

2 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-26-115
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
May 25, 2026 *May 25, 2026 *Not ApplicableNovember 2026January 2027April 2027
May 25, 2027 *May 25, 2027 *Not ApplicableNovember 2027January 2028April 2028
May 25, 2028 *May 25, 2028 *Not ApplicableNovember 2028January 2029April 2029

What its predecessor PAR-23-248 funded

PAR-26-115 reissues PAR-23-248. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 24 projects and $28.5M in FY2022–FY2026.

Projects funded

24

Distinct projects, FY2022–FY2026

New awards

18

Type 1 (new project) award records

NIH funding

$28.5M

Award dollars under PAR-23-248, FY2022–FY2026

Funding by fiscal year

Award records, new awards, and funding by fiscal year under PAR-23-248
Fiscal yearAward recordsNew awardsFunding
FY202200$0
FY202300$0
FY20241010$6.0M
FY2025186$9.7M
FY2026262$12.8M

Institutions with the most funding

  1. Brigham and Women's Hospital$6.3M · 2 projects
  2. University of Pennsylvania$3.9M · 2 projects
  3. University of Washington$3.2M · 2 projects
  4. Baylor College of Medicine$2.5M · 2 projects
  5. Mayo Clinic Rochester$2.5M · 2 projects

Funding institutes

  • NIDDK$28.5M · 54

Activity codes funded

  • TL129 records
  • U2C25 records

FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.

Participating institutes

2 NIH institutes and offices take applications under PAR-26-115. Contact the program officer at the institute that fits your research before applying.

  • NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
  • none

Related notices

NIH lists no related notices for PAR-26-115 yet.

Award terms

Application types allowed
New Renewal Resubmission The OER Glossary and the How to Apply - Application Guide provides details on these application types. Only those application types listed here are allowed for this NOFO.
Award budget
The total costs of the U2C Administrative Core plus Networking and Professional Development Core) should not exceed 40% of the total cost of the TL1 NRSA Training Core). In other words, the total costs of the U2C divided by the total costs of the TL1 should not exceed 0.40.
Project period
The scope of the proposed project should determine the project period. The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
Funds available and number of awards
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

Related NOFOs

  • Reissue of PAR-23-248.

Other open NOFOs for U2C

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO